Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Bone Neoplasms × Bone Cements × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Chest Wall Tumor 1 Bone Neoplasms 1

Interventions

Gemcitabine 6 Doxorubicin 4 pembrolizumab 3 Magnetic Resonance Spectroscopy 3 Docetaxel 3 Cyclophosphamide 3 Cisplatin 3 Vincristine 2 Tranexamic Acid 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Nivolumab 2 Methotrexate 2 Methods 2 Interviews as Topic 2 Indocyanine Green 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 tocilizumab 1 samarium Sm-153 lexidronam 1 regorafenib 1 poly ICLC 1 pegfilgrastim 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 fludarabine 1 flt3 ligand protein 1 endostar protein 1 eltrombopag 1 dinutuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03427632 2018-02-09

PVP

Assiut University

Bone Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡